ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Bush Increase For NIH In Sharp Contrast To Cuts In Health Delivery Programs.

April 6, 2001

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

Reviewers Found For Chronobiolgy

June 30, 1989

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981